BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 15089797)

  • 1. Long-term effects of self-management education for patients with Type 2 diabetes taking maximal oral hypoglycaemic therapy: a randomized trial in primary care.
    Goudswaard AN; Stolk RP; Zuithoff NP; de Valk HW; Rutten GE
    Diabet Med; 2004 May; 21(5):491-6. PubMed ID: 15089797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The management of people with type 2 diabetes with hypoglycaemic agents in primary care: retrospective cohort study.
    Calvert MJ; McManus RJ; Freemantle N
    Fam Pract; 2007 Jun; 24(3):224-9. PubMed ID: 17488736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of motivational interviewing on glycaemic control and perceived competence of diabetes self-management in patients with type 1 and type 2 diabetes mellitus after attending a group education programme: a randomised controlled trial.
    Rosenbek Minet LK; Wagner L; Lønvig EM; Hjelmborg J; Henriksen JE
    Diabetologia; 2011 Jul; 54(7):1620-9. PubMed ID: 21455729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethnic differences in glycaemic control in adult Type 2 diabetic patients in primary care: a 3-year follow-up study.
    Ng TP; Goh LG; Tan Y; Tan E; Leong H; Tay EG; Thai AC
    Diabet Med; 2005 Nov; 22(11):1598-604. PubMed ID: 16241927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimization of insulin therapy in patients with type 2 diabetes mellitus: beyond basal insulin.
    Blak BT; Smith HT; Hards M; Curtis BH; Ivanyi T
    Diabet Med; 2012 Jul; 29(7):e13-20. PubMed ID: 22268988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient-directed titration for achieving glycaemic goals using a once-daily basal insulin analogue: an assessment of two different fasting plasma glucose targets - the TITRATE study.
    Blonde L; Merilainen M; Karwe V; Raskin P;
    Diabetes Obes Metab; 2009 Jun; 11(6):623-31. PubMed ID: 19515182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction in glycated albumin can predict change in HbA1c: comparison of oral hypoglycaemic agent and insulin treatments.
    Won HK; Kim KJ; Lee BW; Kang ES; Cha BS; Lee HC
    Diabet Med; 2012 Jan; 29(1):74-9. PubMed ID: 21781151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attainment of glycaemic goals in type 2 diabetes with once-, twice-, or thrice-daily dosing with biphasic insulin aspart 70/30 (The 1-2-3 study).
    Garber AJ; Wahlen J; Wahl T; Bressler P; Braceras R; Allen E; Jain R
    Diabetes Obes Metab; 2006 Jan; 8(1):58-66. PubMed ID: 16367883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between self-monitored blood glucose values and glycated haemoglobin in insulin-treated patients with Type 2 diabetes.
    Sarwat S; Ilag LL; Carey MA; Shrom DS; Heine RJ
    Diabet Med; 2010 May; 27(5):589-92. PubMed ID: 20536957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of biphasic insulin aspart 30 given three times daily or twice daily in combination with metformin versus oral antidiabetic drugs alone in patients with poorly controlled type 2 diabetes: a 16-week, randomized, open-label, parallel-group trial conducted in russia.
    Ushakova O; Sokolovskaya V; Morozova A; Valeeva F; Zanozina O; Sazonova O; Zhadanova E; Starceva M; Kazakova E; Saifullina M; Shapiro I; Tarasov A; Al-Tayar B; Starkova N
    Clin Ther; 2007 Nov; 29(11):2374-84. PubMed ID: 18158078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical clinics versus usual care for patients with both diabetes and hypertension: a randomized trial.
    Edelman D; Fredrickson SK; Melnyk SD; Coffman CJ; Jeffreys AS; Datta S; Jackson GL; Harris AC; Hamilton NS; Stewart H; Stein J; Weinberger M
    Ann Intern Med; 2010 Jun; 152(11):689-96. PubMed ID: 20513826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Self-titration of biphasic insulin aspart 30/70 improves glycaemic control and allows easy intensification in a Dutch clinical practice.
    Ligthelm RJ
    Prim Care Diabetes; 2009 May; 3(2):97-102. PubMed ID: 19285933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomised, controlled trial of self-monitoring of blood glucose in patients with type 2 diabetes receiving conventional insulin treatment.
    Nauck MA; Haastert B; Trautner C; Müller UA; Nauck MA; Heinemann L;
    Diabetologia; 2014 May; 57(5):868-77. PubMed ID: 24445534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of glycaemic control in patients with Type 1 diabetes commencing continuous subcutaneous insulin infusion therapy.
    Shalitin S; Gil M; Nimri R; de Vries L; Gavan MY; Phillip M
    Diabet Med; 2010 Mar; 27(3):339-47. PubMed ID: 20536498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Addition of biphasic insulin aspart 30 to optimized metformin and pioglitazone treatment of type 2 diabetes mellitus: The ACTION Study (Achieving Control Through Insulin plus Oral ageNts).
    Raskin P; Matfin G; Schwartz SL; Chaykin L; Chu PL; Braceras R; Wynne A
    Diabetes Obes Metab; 2009 Jan; 11(1):27-32. PubMed ID: 17941873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin lispro protamine suspension in intensive insulin treatment: an Italian observational study.
    Citro G; Lorusso B; Rossi A; Romaniello M; Gentilella R; Cremasco F
    Curr Med Res Opin; 2009 Sep; 25(9):2259-65. PubMed ID: 19630489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of injection-meal interval usage and its association with variables of metabolic control in patients with Type 1 and Type 2 diabetes.
    Müller N; Kloos C; Frank T; Ristow M; Wolf G; Müller UA
    Diabet Med; 2011 Feb; 28(2):223-6. PubMed ID: 21219434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ROSES: role of self-monitoring of blood glucose and intensive education in patients with Type 2 diabetes not receiving insulin. A pilot randomized clinical trial.
    Franciosi M; Lucisano G; Pellegrini F; Cantarello A; Consoli A; Cucco L; Ghidelli R; Sartore G; Sciangula L; Nicolucci A;
    Diabet Med; 2011 Jul; 28(7):789-96. PubMed ID: 21342243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A(1c) control in a primary care setting: self-titrating an insulin analog pre-mix (INITIATEplus trial).
    Oyer DS; Shepherd MD; Coulter FC; Bhargava A; Brett J; Chu PL; Trippe BS;
    Am J Med; 2009 Nov; 122(11):1043-9. PubMed ID: 19854333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.